United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-090_4ed84766-51d2-3f2e-e063-6294a90a4109
- Product NDC
- 85766-090
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181221
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZONATATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (85766-090-01) · 85766-090-01
- 500 CAPSULE in 1 BOTTLE (85766-090-05) · 85766-090-05
- 10 CAPSULE in 1 BOTTLE (85766-090-10) · 85766-090-10
- 20 CAPSULE in 1 BOTTLE (85766-090-20) · 85766-090-20
- 21 CAPSULE in 1 BOTTLE (85766-090-21) · 85766-090-21
- 30 CAPSULE in 1 BOTTLE (85766-090-30) · 85766-090-30
- 60 CAPSULE in 1 BOTTLE (85766-090-60) · 85766-090-60
- 90 CAPSULE in 1 BOTTLE (85766-090-90) · 85766-090-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →